Trial Profile

A Comparison of the Efficacy and Safety of Topiramate Versus Placebo for the Prophylaxis of Chronic Migraine

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 17 Nov 2009

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Topiramate (Primary)
Indications Migraine
Focus Therapeutic Use
Sponsors Janssen Research & Development

Most Recent Events

01 Sep 2009 Results for pre-specified secondary endpoints have been published in Headache.
05 May 2009 Actual number of patients added as 328.
11 Oct 2007 Status changed from in progress to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com